Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -259,581 | -197,556 | -123,580 | -92,064 | -52,894 |
| Depreciation Amortization | 3,005 | -2,252 | -376 | 971 | 904 |
| Accounts payable and accrued liabilities | -2,964 | 12,706 | 1,507 | 369 | -250 |
| Other Working Capital | 2,983 | 10,008 | 2,671 | 416 | 418 |
| Other Operating Activity | 51,423 | 18,205 | 18,529 | 11,599 | 19,154 |
| Operating Cash Flow | $-205,134 | $-158,889 | $-101,249 | $-78,709 | $-32,668 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -271,062 | 96,942 | -385,081 | 59,705 | 10,415 |
| PPE Investments | -46,791 | -6,917 | -1,198 | -1,028 | -1,521 |
| Investing Cash Flow | $-317,853 | $90,025 | $-386,279 | $58,677 | $8,894 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,663 | 6,443 | 25,713 | 6,278 | 97,546 |
| Other Financing Activity | 566,759 | -312 | 398,594 | 52,410 | -642 |
| Financing Cash Flow | $576,422 | $6,131 | $424,307 | $58,688 | $96,904 |
| Beginning Cash Position | 19,419 | 82,152 | 145,373 | 106,717 | 33,587 |
| End Cash Position | 72,854 | 19,419 | 82,152 | 145,373 | 106,717 |
| Net Cash Flow | $53,435 | $-62,733 | $-63,221 | $38,656 | $73,130 |
| Free Cash Flow | |||||
| Operating Cash Flow | -205,134 | -158,889 | -101,249 | -78,709 | -32,668 |
| Capital Expenditure | -46,791 | -6,917 | -1,198 | -1,028 | -1,521 |
| Free Cash Flow | -251,925 | -165,806 | -102,447 | -79,737 | -34,189 |